FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3150446579> ?p ?o ?g. }

• W3150446579 endingPage "298" @default.
• W3150446579 startingPage "293" @default.
• W3150446579 abstract "OBJECTIVE To observe the effects of veno-venous extracorporeal membrane oxygenation (VV-ECMO) combined with prone position ventilation (PPV) on oxygenation index (PaO2/FiO2), respiratory compliance (Crs) and vasoactive inotropic score (VIS) in severe acute respiratory distress syndrome (ARDS) patients. METHODS Eighteen patients with severe ARDS requiring VV-ECMO support in Liuzhou People's Hospital from June 2018 to April 2020 were selected for retrospective analysis, and 8 patients among of these cases received PPV after VV-ECMO. The differences in PaO2/FiO2, VIS and Crs before and 1, 2 or 3 days after treatment were compared between VV-ECMO group and VV-ECMO combined with PPV group, as well as the differences in these indices before PPV and 2 hours after PPV daily in VV-ECMO combined with PPV group. The incidence of adverse events in two groups were also observed. RESULTS Before treatment, there was no significant difference in PaO2/FiO2, Crs between two groups. Over time, PaO2/FiO2 and Crs increased and VIS decreased in both groups. Compared with before treatment, there were statistically significant differences in PaO2/FiO2 and VIS from 1 day after treatment [PaO2/FiO2 (mmHg, 1 mmHg = 0.133 kPa): VV-ECMO group was 197.75±39.80 vs. 75.57±7.44, VV-ECMO combined with PPV group was 255.20±31.92 vs. 68.24±11.64; VIS: VV-ECMO group was 5.51±3.72 vs. 10.20±7.10, VV-ECMO combined with PPV group was 6.73±3.32 vs. 14.50±2.48, all P < 0.05], up to 3 days after treatment [PaO2/FiO2 (mmHg): VV-ECMO group was 231.96±32.76 vs. 75.57±7.44, VV-ECMO combined with PPV group was 285.61±19.40 vs. 68.24±11.64; VIS: VV-ECMO group was 2.26±1.90 vs. 10.20±7.10, VV-ECMO combined with PPV group was 2.13±1.55 vs. 14.50±2.48, all P < 0.05], and the PaO2/FiO2 1 day and 3 days after treatment in VV-ECMO combined with PPV group were significantly higher than those in VV-ECMO group (mmHg: after 1 day of treatment was 255.20±31.92 vs. 197.75±39.80, after 3 days of treatment was 285.61±19.40 vs. 231.96±32.76, both P < 0.05). Before treatment, Crs of VV-ECMO combined with PPV group was significantly lower than that of VV-ECMO group (mL/cmH2O: 17.91±0.82 vs. 20.54±1.26, P < 0.05). From 1 day after treatment, the Crs in VV-ECMO combined with PPV group was significantly higher than that before treatment (mL/cmH2O: 21.20±1.50 vs. 17.91±0.82), the peak value was (24.93±2.18) mL/cmH2O on 3 days after treatment, however, there was no significant difference between the two groups (all P < 0.05). In VV-ECMO combined with PPV group, compared with before PPV treatment, the PaO2/FiO2 and Crs of 2 hours after PPV treatment in 1, 2 and 3 days were significantly rose, and it reached the highest level in 3 days [PaO2/FiO2 (mmHg): 285.61±19.40 vs. 189.91±28.34, Crs (mL/cmH2O): 24.93±2.18 vs. 23.35±1.45, both P < 0.05]; the VIS was only increased in 2 hours after PPV treatment on the first day than before (6.73±3.32 vs. 6.38±3.22, P < 0.05). There were no related serious adverse events happened after PPV treatment. CONCLUSIONS The combination of PPV during VV-ECMO could further increase PaO2/FiO2, improve hypoxemia and implement further protective lung ventilation to reduce the potential hazards during mechanical ventilation. In addition, no serious adverse events were observed in this study, suggesting PPV is safe during VV-ECMO." @default.
• W3150446579 created "2021-04-13" @default.
• W3150446579 creator A5005305428 @default.
• W3150446579 creator A5026620151 @default.
• W3150446579 creator A5057993164 @default.
• W3150446579 creator A5059044552 @default.
• W3150446579 creator A5077575842 @default.
• W3150446579 date "2021-03-01" @default.
• W3150446579 modified "2023-09-26" @default.
• W3150446579 title "[Comparison of efficacy between veno-venous extracorporeal membrane oxygenation (VV-ECMO) and VV-ECMO combined with prone position ventilation for the treatment of acute respiratory distress syndrome]." @default.
• W3150446579 doi "https://doi.org/10.3760/cma.j.cn121430-20200805-00563" @default.
• W3150446579 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33834969" @default.
• W3150446579 hasPublicationYear "2021" @default.
• W3150446579 type Work @default.
• W3150446579 sameAs 3150446579 @default.
• W3150446579 citedByCount "1" @default.
• W3150446579 countsByYear W31504465792021 @default.
• W3150446579 crossrefType "journal-article" @default.
• W3150446579 hasAuthorship W3150446579A5005305428 @default.
• W3150446579 hasAuthorship W3150446579A5026620151 @default.
• W3150446579 hasAuthorship W3150446579A5057993164 @default.
• W3150446579 hasAuthorship W3150446579A5059044552 @default.
• W3150446579 hasAuthorship W3150446579A5077575842 @default.
• W3150446579 hasConcept C126322002 @default.
• W3150446579 hasConcept C163100246 @default.
• W3150446579 hasConcept C2776348555 @default.
• W3150446579 hasConcept C2776858399 @default.
• W3150446579 hasConcept C2777080012 @default.
• W3150446579 hasConcept C2777714996 @default.
• W3150446579 hasConcept C2780826366 @default.
• W3150446579 hasConcept C2909621147 @default.
• W3150446579 hasConcept C42219234 @default.
• W3150446579 hasConcept C70289976 @default.
• W3150446579 hasConcept C71924100 @default.
• W3150446579 hasConceptScore W3150446579C126322002 @default.
• W3150446579 hasConceptScore W3150446579C163100246 @default.
• W3150446579 hasConceptScore W3150446579C2776348555 @default.
• W3150446579 hasConceptScore W3150446579C2776858399 @default.
• W3150446579 hasConceptScore W3150446579C2777080012 @default.
• W3150446579 hasConceptScore W3150446579C2777714996 @default.
• W3150446579 hasConceptScore W3150446579C2780826366 @default.
• W3150446579 hasConceptScore W3150446579C2909621147 @default.
• W3150446579 hasConceptScore W3150446579C42219234 @default.
• W3150446579 hasConceptScore W3150446579C70289976 @default.
• W3150446579 hasConceptScore W3150446579C71924100 @default.
• W3150446579 hasIssue "3" @default.
• W3150446579 hasLocation W31504465791 @default.
• W3150446579 hasOpenAccess W3150446579 @default.
• W3150446579 hasPrimaryLocation W31504465791 @default.
• W3150446579 hasRelatedWork W190726968 @default.
• W3150446579 hasRelatedWork W2063680570 @default.
• W3150446579 hasRelatedWork W2094668285 @default.
• W3150446579 hasRelatedWork W2400342248 @default.
• W3150446579 hasRelatedWork W2410008133 @default.
• W3150446579 hasRelatedWork W2465149377 @default.
• W3150446579 hasRelatedWork W2617673192 @default.
• W3150446579 hasRelatedWork W2774210488 @default.
• W3150446579 hasRelatedWork W2969557841 @default.
• W3150446579 hasRelatedWork W2990652088 @default.
• W3150446579 hasRelatedWork W3005735581 @default.
• W3150446579 hasRelatedWork W3017109528 @default.
• W3150446579 hasRelatedWork W3029586673 @default.
• W3150446579 hasRelatedWork W3030063026 @default.
• W3150446579 hasRelatedWork W3044827404 @default.
• W3150446579 hasRelatedWork W3120520476 @default.
• W3150446579 hasRelatedWork W3134887903 @default.
• W3150446579 hasRelatedWork W3138262243 @default.
• W3150446579 hasRelatedWork W3175055516 @default.
• W3150446579 hasRelatedWork W3208850695 @default.
• W3150446579 hasVolume "33" @default.
• W3150446579 isParatext "false" @default.
• W3150446579 isRetracted "false" @default.
• W3150446579 magId "3150446579" @default.
• W3150446579 workType "article" @default.